Why Cybersecurity Is Now Central to the Patient Experience
Cybersecurity is no longer a function managed in the IT department’s back office. It’s a…
Why Cybersecurity Is Now Central to the Patient Experience
Cybersecurity is no longer a function managed in the IT department’s back office. It’s a front-line brand issue, with real implications for patient satisfaction and loyalty. That means providers need to rethink how they talk about security. It’s no longer enough to be secure; you must communicate security clearly. The post Why Cybersecurity Is Now…
Impact of cousin marriage on life expectancy
From Hwang, Jakob and Squires (2025) in AER: Insights: Cousin marriage rates are high in many countries today. While previous studies have documented increased risks of infant and child mortality, we provide the first estimate of the effect of such marriages on life expectancy throughout adulthood. By studying couples married over a century ago, we…
Better Prompting May Help Reduce AI Hallucinations, False Vaccine Claims Spread, and Industrial Solvent Promoted as Hidden Cancer Cure — The Monitor
This volume examines how prompting techniques can reduce incorrect medical information from AI chatbots; false claims linking vaccines to sudden infant death syndrome; the promotion of an industrial solvent as an allegedly suppressed cancer cure; misunderstandings about the risks of overdose from fentanyl exposure; and ongoing myths about sunscreen safety.
Public Health Is Not the Hudson River
By GREGORY HOPSON There is no doubt Robert F. Kennedy, Jr. is sincere about wanting to make the world a better place. The Hudson River cleanup, which he helped lead, is one of the most successful environmental achievements in the United States. It had bipartisan support, set global standards, and earned the highest compliment: imitation….
EVERSANA, Waltz Health Merge to Create $6B Prescription Drug Company
EVERSANA is merging with Waltz Health under the EVERSANA name. Mark Thierer, co-founder and CEO of Waltz Health, will serve as the CEO of the combined company. The post EVERSANA, Waltz Health Merge to Create $6B Prescription Drug Company appeared first on MedCity News.
European Commission Approval Gives Blood Cancer Patients a New Cell Therapy Option
Zemcelpro, a cord blood-sourced cell therapy developed by startup ExCellThera, received conditional marketing authorization in Europe as a treatment for blood cancer patients who can’t find a matched donor. It’s the first cell therapy approved in Europe for this group of patients. The post European Commission Approval Gives Blood Cancer Patients a New Cell Therapy…
CDC Director Ousted After Less Than a Month on the Job
Susan Monarez has left her role as CDC director after less than a month — the shortest tenure in the agency’s history — following reported clashes with HHS Secretary Robert F. Kennedy Jr. over vaccine policy. This news comes amid a period of turmoil at the CDC, including a recent deadly shooting at its headquarters….
Do people like to daydream?
Not really. At least according a study by Wilson et al. 2025 in Science. In 11 studies, we found that participants typically did not enjoy spending 6 to 15 minutes in a room by themselves with nothing to do but think, that they enjoyed doing mundane external activities much more, and that many preferred to…
Bringing Clinical Data Management to the Cloud
Moving clinical data management to cloud platforms can carry myriad benefits for healthcare organizations. The post Bringing Clinical Data Management to the Cloud appeared first on MedCity News.
CMS doesn’t consider QALYs – What’s a health economist to do?
That is the title of my article out today in The Evidence Base. Here is an excerpt: The Centers for Medicare and Medicaid Services (CMS) are now setting drug prices under the Medicare Drug Price Negotiation program. Unlike other health technology assessment (HTA) bodies worldwide, however, CMS will not consider quality-adjusted life years (QALYs) when setting drug…
